Copyright Reports & Markets. All rights reserved.

Global Histone Deacetylase 6 Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Histone Deacetylase 6

      • 1.1 Definition of Histone Deacetylase 6
      • 1.2 Histone Deacetylase 6 Segment by Type
        • 1.2.1 Global Histone Deacetylase 6 Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Citarinostat
        • 1.2.3 CKD-504
        • 1.2.4 ACY-738
        • 1.2.5 HG-3001
        • 1.2.6 MPT-0B291
        • 1.2.7 Ricolinostat
        • 1.2.8 Others
      • 1.3 Histone Deacetylase 6 Segment by Applications
        • 1.3.1 Global Histone Deacetylase 6 Consumption Comparison by Applications (2014-2025)
        • 1.3.2 CNS Lymphoma
        • 1.3.3 Colon Cancer
        • 1.3.4 Huntington Disease
        • 1.3.5 Inflammation
        • 1.3.6 Others
      • 1.4 Global Histone Deacetylase 6 Overall Market
        • 1.4.1 Global Histone Deacetylase 6 Revenue (2014-2025)
        • 1.4.2 Global Histone Deacetylase 6 Production (2014-2025)
        • 1.4.3 North America Histone Deacetylase 6 Status and Prospect (2014-2025)
        • 1.4.4 Europe Histone Deacetylase 6 Status and Prospect (2014-2025)
        • 1.4.5 China Histone Deacetylase 6 Status and Prospect (2014-2025)
        • 1.4.6 Japan Histone Deacetylase 6 Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Histone Deacetylase 6 Status and Prospect (2014-2025)
        • 1.4.8 India Histone Deacetylase 6 Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Histone Deacetylase 6
      • 2.3 Manufacturing Process Analysis of Histone Deacetylase 6
      • 2.4 Industry Chain Structure of Histone Deacetylase 6

      3 Development and Manufacturing Plants Analysis of Histone Deacetylase 6

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Histone Deacetylase 6 Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Histone Deacetylase 6
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Histone Deacetylase 6 Production and Capacity Analysis
      • 4.2 Histone Deacetylase 6 Revenue Analysis
      • 4.3 Histone Deacetylase 6 Price Analysis
      • 4.4 Market Concentration Degree

      5 Histone Deacetylase 6 Regional Market Analysis

      • 5.1 Histone Deacetylase 6 Production by Regions
        • 5.1.1 Global Histone Deacetylase 6 Production by Regions
        • 5.1.2 Global Histone Deacetylase 6 Revenue by Regions
      • 5.2 Histone Deacetylase 6 Consumption by Regions
      • 5.3 North America Histone Deacetylase 6 Market Analysis
        • 5.3.1 North America Histone Deacetylase 6 Production
        • 5.3.2 North America Histone Deacetylase 6 Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Histone Deacetylase 6 Import and Export
      • 5.4 Europe Histone Deacetylase 6 Market Analysis
        • 5.4.1 Europe Histone Deacetylase 6 Production
        • 5.4.2 Europe Histone Deacetylase 6 Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Histone Deacetylase 6 Import and Export
      • 5.5 China Histone Deacetylase 6 Market Analysis
        • 5.5.1 China Histone Deacetylase 6 Production
        • 5.5.2 China Histone Deacetylase 6 Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Histone Deacetylase 6 Import and Export
      • 5.6 Japan Histone Deacetylase 6 Market Analysis
        • 5.6.1 Japan Histone Deacetylase 6 Production
        • 5.6.2 Japan Histone Deacetylase 6 Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Histone Deacetylase 6 Import and Export
      • 5.7 Southeast Asia Histone Deacetylase 6 Market Analysis
        • 5.7.1 Southeast Asia Histone Deacetylase 6 Production
        • 5.7.2 Southeast Asia Histone Deacetylase 6 Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Histone Deacetylase 6 Import and Export
      • 5.8 India Histone Deacetylase 6 Market Analysis
        • 5.8.1 India Histone Deacetylase 6 Production
        • 5.8.2 India Histone Deacetylase 6 Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Histone Deacetylase 6 Import and Export

      6 Histone Deacetylase 6 Segment Market Analysis (by Type)

      • 6.1 Global Histone Deacetylase 6 Production by Type
      • 6.2 Global Histone Deacetylase 6 Revenue by Type
      • 6.3 Histone Deacetylase 6 Price by Type

      7 Histone Deacetylase 6 Segment Market Analysis (by Application)

      • 7.1 Global Histone Deacetylase 6 Consumption by Application
      • 7.2 Global Histone Deacetylase 6 Consumption Market Share by Application (2014-2019)

      8 Histone Deacetylase 6 Major Manufacturers Analysis

      • 8.1 Celgene Corp
        • 8.1.1 Celgene Corp Histone Deacetylase 6 Production Sites and Area Served
        • 8.1.2 Celgene Corp Product Introduction, Application and Specification
        • 8.1.3 Celgene Corp Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Chong Kun Dang Pharmaceutical Corp
        • 8.2.1 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Production Sites and Area Served
        • 8.2.2 Chong Kun Dang Pharmaceutical Corp Product Introduction, Application and Specification
        • 8.2.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Curis Inc
        • 8.3.1 Curis Inc Histone Deacetylase 6 Production Sites and Area Served
        • 8.3.2 Curis Inc Product Introduction, Application and Specification
        • 8.3.3 Curis Inc Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 HitGen LTD
        • 8.4.1 HitGen LTD Histone Deacetylase 6 Production Sites and Area Served
        • 8.4.2 HitGen LTD Product Introduction, Application and Specification
        • 8.4.3 HitGen LTD Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Kancera AB
        • 8.5.1 Kancera AB Histone Deacetylase 6 Production Sites and Area Served
        • 8.5.2 Kancera AB Product Introduction, Application and Specification
        • 8.5.3 Kancera AB Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Karus Therapeutics Ltd
        • 8.6.1 Karus Therapeutics Ltd Histone Deacetylase 6 Production Sites and Area Served
        • 8.6.2 Karus Therapeutics Ltd Product Introduction, Application and Specification
        • 8.6.3 Karus Therapeutics Ltd Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Medivir AB
        • 8.7.1 Medivir AB Histone Deacetylase 6 Production Sites and Area Served
        • 8.7.2 Medivir AB Product Introduction, Application and Specification
        • 8.7.3 Medivir AB Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Merck & Co Inc
        • 8.8.1 Merck & Co Inc Histone Deacetylase 6 Production Sites and Area Served
        • 8.8.2 Merck & Co Inc Product Introduction, Application and Specification
        • 8.8.3 Merck & Co Inc Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Millennium Pharmaceuticals Inc
        • 8.9.1 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Production Sites and Area Served
        • 8.9.2 Millennium Pharmaceuticals Inc Product Introduction, Application and Specification
        • 8.9.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 OnKure Inc
        • 8.10.1 OnKure Inc Histone Deacetylase 6 Production Sites and Area Served
        • 8.10.2 OnKure Inc Product Introduction, Application and Specification
        • 8.10.3 OnKure Inc Histone Deacetylase 6 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Quimatryx SL
      • 8.12 Shuttle Pharmaceuticals LLC
      • 8.13 Sigma-Tau SpA
      • 8.14 SK Biopharmaceuticals Co Ltd

      9 Development Trend of Analysis of Histone Deacetylase 6 Market

      • 9.1 Global Histone Deacetylase 6 Market Trend Analysis
        • 9.1.1 Global Histone Deacetylase 6 Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Histone Deacetylase 6 Regional Market Trend
        • 9.2.1 North America Histone Deacetylase 6 Forecast 2019-2025
        • 9.2.2 Europe Histone Deacetylase 6 Forecast 2019-2025
        • 9.2.3 China Histone Deacetylase 6 Forecast 2019-2025
        • 9.2.4 Japan Histone Deacetylase 6 Forecast 2019-2025
        • 9.2.5 Southeast Asia Histone Deacetylase 6 Forecast 2019-2025
        • 9.2.6 India Histone Deacetylase 6 Forecast 2019-2025
      • 9.3 Histone Deacetylase 6 Market Trend (Product Type)
      • 9.4 Histone Deacetylase 6 Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Histone Deacetylase 6 Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Histone Deacetylase 6 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Histone Deacetylase 6 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Histone Deacetylase 6 market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Histone Deacetylase 6 in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Histone Deacetylase 6 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Celgene Corp
        Chong Kun Dang Pharmaceutical Corp
        Curis Inc
        HitGen LTD
        Kancera AB
        Karus Therapeutics Ltd
        Medivir AB
        Merck & Co Inc
        Millennium Pharmaceuticals Inc
        OnKure Inc
        Quimatryx SL
        Shuttle Pharmaceuticals LLC
        Sigma-Tau SpA
        SK Biopharmaceuticals Co Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Citarinostat
        CKD-504
        ACY-738
        HG-3001
        MPT-0B291
        Ricolinostat
        Others

        Segment by Application
        CNS Lymphoma
        Colon Cancer
        Huntington Disease
        Inflammation
        Others

        Buy now